Luiza Moore, MD, Phd, FRCPath

is the Global Commercial Product Leader – AI Enabled Assays, at Leica Biosystems. She is a physician-scientist and global leader in oncology diagnostics at Leica Biosystems, focused on digital and computational pathology and the commercialization of innovative diagnostic solutions. 

With more than 15 years of experience spanning clinical medicine, academia, technology, and biopharma, she brings a unique cross-sector perspective shaped by roles as a practicing pathologist, academic researcher, and industry leader across global technology organizations, health tech startups, and pharmaceutical companies. Her work is focused on advancing precision medicine through the development and real-world deployment of AI-enabled diagnostics at scale.